Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria, reports Sohini Das. IMAGE: A woman receives a dose of Covishield at a vaccination centre......
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......
India's apex drug regulator has waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such......
The United Kingdom on Sunday eased travel restrictions for India by moving the country from its "red" to "amber" list, which means fully vaccinated Indian passengers will no longer be subjected to......
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......
Ranbaxy Ltd has been asked by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the largest drug regulator in Europe, to recall its drugs used to treat skin infections.Ranbaxy (UK)......
UK health regulatory authority enforces strict norms for export, in wake of EU directive. Indian ayurvedic medicines manufacturers are set to face a tough time as far as exports to European......
According to the chairman, there will be an annual loss of Rs 100 crore due to the MHRA alert on Waluj plant Following the import alert issued by the US FDA, another global medical regulator, UK......
The company’s revenue from the European market is pegged at around euro 160 million. Of this, UK makes up for euro 110 million, followed by Ireland at euro 30 million and rest from France and......
Pharmaceutical firm Wockhardt Ltd said on Saturday it has received a warning letter from US health regulator over its facility at Waluj in Maharashtra not meeting manufacturing norms. The company......